Puma Biotechnology | Costo Del Venduto





Costo Del Venduto Cambiamento Data
Agios Pharmaceuticals USD 1.68M 22K 2025-09
Alnylam Pharmaceuticals USD 200.15M 57.2M 2025-09
Amgen USD 1.79B 128M 2025-12
Biogen USD 810.1M 205.1M 2025-09
BioMarin Pharmaceutical USD 144.93M 10M 2025-09
Daiichi Sankyo JPY 118.28B 37.7B 2025-12
Esperion Therapeutics USD 51.63M 22.2M 2024-09
Exelixis USD 26.48M 7.91M 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
Glaxosmithkline GBP 3.01B 853.01M 2025-09
Incyte USD 121.18M 22.18M 2025-12
MacroGenics USD 44.3M 5.4M 2025-09
Moderna USD 207M 88M 2025-09
Novartis USD 3.54B 217M 2025-09
Pfizer USD 6.29B 2.12B 2025-12
PTC Therapeutics USD 23.32M 7.83M 2025-09
Puma Biotechnology USD 29.1M 18.44M 2024-09
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sangamo BioSciences 2.42M 1.11M 2024-06
Sarepta Therapeutics USD 151.45M 1.77M 2025-09
Takeda JPY 401.15B 184.07B 2025-12
TG Therapeutics USD 28.09M 9.15M 2025-09
Ultragenyx Pharmaceutical USD 27.99M 4.99M 2025-09
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12
Vertex Pharmaceuticals USD 414.8M 7.3M 2025-09


Puma Biotechnology Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.